Undervalued Small Caps With Insider Buying

Results

57

6 new

Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.

57 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	SHBI	US$23.34	-2.6%	39.0%	US$772.2m	US$25.75	1.3	8.1%	2.4%	Banks
	AUBN	US$26.92	2.6%	9.6%	US$91.1m	n/a	1.0	n/a	4.0%	Banks
	UNB	US$23.99	-2.4%	-11.8%	US$117.7m	n/a	1.3	n/a	6.0%	Banks
	SMWB	US$8.24	-7.3%	-9.7%	US$720.1m	US$10.80	2.5	117.0%	n/a	Software
	ORN	US$9.27	-6.6%	33.0%	US$371.7m	US$15.32	104.2	56.0%	n/a	Capital Goods
	BMRC	US$26.91	-4.9%	11.0%	US$431.0m	US$31.80	1.1	102.5%	3.7%	Banks
	ILPT	US$8.30	-7.0%	35.4%	US$556.7m	US$11.17	1.2	20.7%	4.8%	Real Estate
	KINS	US$19.83	0.7%	43.1%	US$284.0m	US$24.00	8.1	14.6%	1.2%	Insurance
	ENOV	US$26.06	0%	-17.1%	US$1.5b	US$40.83	0.7	136.9%	n/a	Healthcare
	BOTJ	US$27.07	-2.5%	80.7%	US$123.4m	n/a	1.5	n/a	1.5%	Banks
	GABC	US$49.90	-2.9%	19.4%	US$1.9b	US$56.20	1.5	5.6%	2.5%	Banks
	HPP	US$14.50	4.3%	-23.0%	US$821.7m	US$17.00	0.3	62.0%	0%	Real Estate
	TRIN	US$18.35	1.2%	16.1%	US$1.7b	US$18.50	12.3	20.8%	11.1%	Diversified Financials
	ALRS	US$32.77	-2.7%	45.8%	US$811.6m	US$35.40	29.6	40.6%	2.7%	Diversified Financials
	ANIK	US$21.78	1.3%	125.7%	US$285.6m	US$21.00	2.4	112.3%	n/a	Pharmaceuticals & Biotech
	FRST	US$16.15	-3.1%	44.8%	US$400.0m	US$19.19	0.9	-2.9%	2.5%	Banks
	EMYB	US$22.35	-0.4%	31.5%	US$165.5m	n/a	1.3	n/a	2.5%	Banks
	PFX New	US$51.22	12.1%	3.5%	US$98.9m	n/a	21.2	26.5%	2.8%	Diversified Financials
	SUNS	US$7.65	-1.3%	-30.9%	US$103.0m	US$10.88	8.1	23.2%	15.7%	Diversified Financials
	FUSB	US$16.24	-1.3%	30.6%	US$90.6m	n/a	0.9	n/a	1.7%	Banks
	AZTA	US$37.40	12.0%	18.5%	US$1.6b	US$34.80	2.7	105.6%	0%	Pharmaceuticals & Biotech
	ENBP	US$29.20	0.6%	58.7%	US$166.1m	n/a	1.0	n/a	2.5%	Banks
	CSR	US$53.96	-3.4%	-7.2%	US$957.3m	US$62.93	1.3	-147.0%	5.7%	Real Estate
	ADTN New	US$7.77	-7.5%	-15.3%	US$631.1m	US$14.67	0.6	92.3%	0%	Tech

Page 1 of 2